Idiopathic thrombocytopenic purpura and MMR vaccine

Archives of Disease in Childhood

Volumn 84, Issue 3, 2001, Pages 227-229

  Miller, E ^a   Waight, P ^a   Farrington, P ^b   Andrews, N ^a   Stowe, J ^c   Taylor, B ^c  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b OPEN UNIVERSITY   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Idiopathic thrombocytopenia purpura; MMR; Vaccine

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; CLINICAL ARTICLE; CORRELATION FUNCTION; DRUG EFFECT; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFECTION PREVENTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT;

FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; INFANT; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MEDICAL RECORD LINKAGE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RISK FACTORS;

EID: 0035078632     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.84.3.227     Document Type: Article

References (11)

1. Thrombocytopenic purpura after a combined vaccine against morbilli, parotitis and rubella
2. Swedish experience of a 2 dose vaccination programme aiming at eliminating measles, mumps and rubella
3. Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report in 23 patients
4. Effect of live measles vaccine on the platelet count
5. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines
6. Relative incidence estimation from case series for vaccine safety evaluation
7. COVER (Cover of Vaccination Evaluated Rapidly): Description of the England and Wales scheme
8. Thrombocytopaenia in childhood; an evaluation of 433 patients
9. Recurrent thrombocytopenic purpura after repeated measles-mumpsrubella vaccination
10. Measles, mumps and rubella - Vaccine use and strategies for elimination of measles, rubella and congenital rubella syndrome and control of mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP)